NEW YORK (360Dx) – A testing platform that uses a robot-guided needle to draw blood could be ready for the doctor's office in a few years, according to one of its developers.

Rutgers University researchers are developing the system, which is integrated with microfluidic chips for sample analysis. According to Martin Yarmush, a professor in the department of biomedical engineering at the university, clinicians could eventually use the system to test for any condition that currently uses protein antibody biomarkers for diagnosis.